10x Genomics (TXG) Net Cash Flow Growth (3y) (2021 - 2026)

10x Genomics (TXG) Net Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Veeva Systems 26.86 Bn 19.54 Bn 662.02 Mn 31.95%
2 BrightSpring Health Services 12.40 Bn 11.52 Bn 482.22 Mn 590.29%
3 Healthequity 7.57 Bn 7.31 Bn 256.31 Mn -23.22%
4 Hinge Health 4.86 Bn 4.55 Bn 154.23 Mn -
5 Doximity 3.78 Bn 3.03 Bn 125.97 Mn 92.69%
6 10x Genomics 3.73 Bn 3.19 Bn 106.18 Mn -47.37%
7 Waystar Holding 3.61 Bn 3.45 Bn 268.04 Mn -
8 Privia Health 2.84 Bn 2.47 Bn 595.71 Mn -17.84%
9 Omnicell 1.73 Bn 1.56 Bn 140.36 Mn 139.35%
10 Teladoc Health 1.27 Bn 518.34 Mn 562.57 Mn -0.39%

Historic Data

Download Data
DateValue
Mar 31, 2026 -47.37%
Dec 31, 2025 69.30%
Sep 30, 2025 42.15%
Jun 30, 2025 36.30%
Mar 31, 2025 28.45%
Dec 31, 2024 -60.95%
Sep 30, 2024 34.94%
Jun 30, 2024 71.77%
Mar 31, 2024 57.46%
Dec 31, 2023 32.14%
Sep 30, 2023 -26.77%
Jun 30, 2023 31.94%
Mar 31, 2023 65.43%
Dec 31, 2022 -144.54%
Sep 30, 2022 -27.98%
Jun 30, 2022 -56.64%
Mar 31, 2022 -582.37%
Dec 31, 2021 10.40%